Ποια είναι η τιμή για Microbix Biosystems Inc. (MBX)

Η τιμή για Microbix Biosystems Inc. (MBX) είναι $0.20917201

Ποια είναι η κεφαλαιοποίηση αγοράς για Microbix Biosystems Inc. (MBX)

Η κεφαλαιοποίηση αγοράς για Microbix Biosystems Inc. (MBX) είναι $28.76M

Microbix Biosystems Inc. (MBX) Τιμή και Κεφαλαιοποίηση Αγοράς

Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A significant part of its business involves producing essential biological reagents for the diagnostic industry. This encompasses antigens vital for immunoassays, alongside its distinctive Quality Assessment and Proficiency (QAP) products. These QAPs are instrumental for clinical laboratories, providing support for proficiency testing, the development and validation of diagnostic assays, and optimizing routine lab operations. Furthermore, Microbix applies its deep biological knowledge and infrastructure to create additional proprietary offerings. Among these are DxTM, a viral transport medium crucial for stabilizing patient specimens prior to laboratory analysis, and Kinlytic Urokinase, a biopharmaceutical thrombolytic drug employed to treat blood clots. The company channels its QAP sales to accreditation organizations, diagnostic companies, and clinical laboratories via an extensive network of regional distributors.

Η τιμή για MBX	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$38,548.94 $28.76M	NVDA	$5.301T	+18,429,200.70%
$33,698.39 $28.76M	AAPL	$4.634T	+16,110,270.72%
$30,128.56 $28.76M	GOOG	$4.143T	+14,403,623.87%
$26,102.61 $28.76M	MSFT	$3.589T	+12,478,918.54%
$20,776.28 $28.76M	AMZN	$2.857T	+9,932,530.96%

Η τιμή για MBX

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$38,548.94 $28.76M